CategoryInvestment ideas

The mirage of holding companies

T

I found these two investment ideas on the blog ‘Indian equity guru’.

http://equityguru.blogspot.com/2006/12/stock-idea-srf-polymers.html
http://equityguru.blogspot.com/2006/11/stock-idea-maharastra-scooters.html

Both the ideas are of holding companies. For ex: SRF polmers has a substaintial holdings of SRF. As a result if you add the value of the business to the value of holdings, the company is selling at a substantial discount to intrinsic value.

One can make a similar case for Balmer lawrie limited and BMIL. Actually I would not be surprised if there are several such stocks available. I find such ideas interesting and cannot argue against the basic logic. What I cannot get my arms around is how will the value get unlocked? There seems to be no catalyst in sight as the holding company is a means for the promoter to exercise control. As a result the holdings may never get sold. What will unlock the value then in such cases?

Somehow these ideas seem to have a mirage like quality. You can see the value out there, but may never gain from it (unless there is an underlying catalyst to unlock the value)

Blue star india – A quick look

B

Blue star india is primarily in the commercial air conditioning and refrigeration business. The three main business segments are

1.Central air conditioning: This is the main business for blue star. It accounts for 70 %+ of the company’s revenue, has been growing at 25 % and has a pre-tax ROCE of almost 60 %. Blue star is fairly dominant in this sector and has a good market share of almost 30%. This sector is dependent on industrial demand, IT/ITES sector and retail. Lately the industrial sector, IT/ITES and retail sector have been boyant due to which Blue star has a good backlog of orders.

2.Cooling products: This comprises of Window, split A/c and other retail products such as water coolers, cold storage etc. This is a fairly competitive segment with strong brands such as carrier aircon and other vendors. This segment had a good volume growth and revenue growth of 30%. However as this segment is competitive, the pre-tax ROCE is at a respectable 15%.

3.Professional electronics and industrial equipment: This segment had a good growth last year on a small base of 60 Crs. The segment is small accounting for less than 10% of the total revenue. The pre-tax ROCE is high at almost 70%+.

Key competitive strengths
Blue star has key advantages via a strong brand in its key segments. It has a good reputation in terms of project execution and after sales service for the institutional segment. There is certain amount of lockin once a customer (especially if it is an institutional one) has selected and installed a blue star system. Subsequent orders would likely be for the same vendor. Due to high market share, blue star has certain demand and production economies of scale, which allows it to be a low cost provider. The central air conditioning segment is project driven, where project skills, experience and scale matters as the margins are fairly low (pre-tax margins were < 10 %) and hence a company has to be efficient to be a profitable business.

Problems areas
The company has performed well on most parameters such as revenue growth, NPM, ROE etc. However for the last 1-2 years, the free cash flow of the company has been dropping. The current year’s FCF was around 40 % of the operating profits. The main culprits have been account recievables and inventory. The recievables ratio has dropped from 6 to 4.9 and the inventory ratio has dropped from 9 to 7.9. The drops are not alarming and are still good in an absolute sense. However they need to be watched closely to see if the growth is not coming a high price (write-offs of bad debts and inventory later)

Valuation
Assuming (a big assumption though), the company can manage its Working capital, the Net profit can be taken as Free cash flow. The last year EPS (post split) was 5.8. The current year EPS should come be conservatively at 7. Using a DCF (with various assumptions) I would value the company roughly at 140-160 Rs/ Share. My personal opinion is that the stock is fairly priced.

Disclosure : I have owned the stock for the past few years.

Hidden Value : Kirloskar oil engines

H

Analysis date: Aug 2006

Kirloskar oil engines, a company from the kirloskar group has two main business segments

Engines: This business segment accounts for almost 80 % of the revenue and is the main business segment. This business caters to the farm sector, power sector, industrial machinery, Construction and material handling equipment. In addition the company has contracts/ relationships with OEM manufacturers, the armed forces and has its own service dealers and service personnels. The company has products in a wide HP ranges and has technical collaborations too. The highest volume comes from the small engines segment followed by the medium engines.

Autocomponents: This business segment accounts for the balance 20% and had an above industry growth due to capacity constraints. In addition the company has OEM relationships with some prominent companies such as maruti, sundaram clayton etc. The main products are valves and bearings

Other business: Some other minor businesses such as manufacturing grey iron castings, trading, power generation and sales (which is under review due to dropping sales)

The Company has benefitted from the recent improvement in the capital goods sector and upturn in the power sector. The period from 1996 to 2001 such low growth (20% in almost 6-7 years). Due to the improvement in the business climate the topline and margins have improved dramatically in the recent past. The company is seeing good volume growth in its core business and has also delivered good performance in the export sector which crossed 100 Crs this year.

Due to the nature of the industry (capital goods) with limited and large buyers, and due to cyclical nature the topline and margins are also cyclical. The NPM has fluctuated between as low as 2-3 % to 15 % in the recent past. I would put the average NPM at 6-7 % over a complete business cycle.

The company has become fairly efficient with the Fixed asset turnover ratios expanding from 4-5 to 7-8 in the recent past. Wcap ratios have gone through a dramatic improvement and is now almost 14. This freeing up of the capital has raised the ROE from 8-10 % to almost 30% +. In addition on a total capital base of 795 Cr, almost 500 Crs is investments.

This 500 Crs of investment at market value is almost 1000cr which translates into almost 95 Rs/ share (net of debt)

Valuation: The last year Netprofit is almost Rs 10 / share (net of exceptional items). With almost 95 Rs / share of investment, I would value the stock at approximately 350 Rs / share (max). There are various assumptions behind this valuation, namely

1. Rs 18/ share for current year’s earnings are during a cyclical high. The average earnings are more like 14-16.

2. Rs 95/ share of investments is not really realisable as a major part of this investment is in other group/ JV’s, which are unlikely to be sold off soon.

3. The company has some competitive advantage such as customer relationships, some economies of scale etc. But in the end it is in a cyclical industry with moderate to weak pricing strength and hence I would not accord the core business a PE multiple of more than 16-18.

A few investment ideas and analysis

A

On running various filters in icicidirect, I was able to list a few companies which were worth further investigation.

My approach was to do a preliminary analysis and reduce the list further to a few more interesting opportunities.

I am listing the companies and my analysis. This analysis is a bit dated as I did this analysis during the aug/sept time frame and have not looked at the recent price for these companies

1. Merck : Indian subsidiary of the american MNC. The american parent has a 100% subsidiary too which could be getting all the new products from the parents portfolio (and I guess special treatment over the listed subsidiary).

The company is selling at approximately 5 times earnings after adjusting non operating income and cash on books. The company has a high ROE of 30 % and low growth of 4-5%. The actual ROE on tangible equity is 60% +.

The company has a Pharmaceuticals and chemicals business. It has recently sold its life sciences business and has approximately 3370 million on its books (Rs 200/ share).

The topline is expected to drop due to the sale of the life sciences business. The pharma business has a growth in single digits and the next years earnings could be 10-15 % over the earnings of 2005 (current year earnings are not comparable due to the sale of life sciences division)

This company is a value play. The management does not seem to be very shareholder friendly. It remains to be seen, what the management will do with the huge cash it has on its books . Will it try to buy out the indian shareholders at an unfair price like a few other MNC’s have done in past? Can happen.

I would estimate the intrinsic value conservatively at 700-800 Rs per share. However it is quite likely that the valuation gap may take a long time to close due to poor growth prospects and a management which may be indifferent to minority shareholders

2. Swaraj engines
The company showed up in my list as the PE seems to be 4-5. However after adjusting for the bonus issue, the actual PE is 14. Also the company has low growth, high debtors position and is mainly supplying to sister companies. It is a small cap company too. I do not see much value in this stock and decided to give it a pass.

The other stocks which I will detail in subsequent posts are

Grindwell norton
Revathi CP
Kirloskar oil engines
Hindustan inks
Tube investments
Neyvelli lignite
Gujarat gas

Please do not take the above list as a recommendation. This above post is just for analysis and I may or may not have invested in any of the above stocks

New ideas

N

Have been away for a while and not posted for quite sometime.
However i have been doing some research for new opportunities and have been finding some good ideas.

Two companies which i am analysing further are
– Kirloskar oil engines limited
– Merck limited

Will update my analysis of these two stocks on the blog once i am done. They are fairly underpriced and look good on a quantitative basis. However i need to analyse in more depth and come to a firm conclusion

Follow up on the Infomedia ltd arbitrage

F

I had a look at the AR of infomedia to figure out what could be the downside risk to the arbitrage opportunity I discussed in my previous post


Following are my observations/ conclusion from what I read in the AR

  • Infomedia is a fairly profitable company with a networth of 155 cr and a cash and equivalents of 126 cr.
  • The company has a Return on capital in excess of 30 % (invested capital net of cash, net profit excluding exceptional items)
  • The company is a zero debt company and is does not have a very capital intensive business.
  • The net profit growth in mid to high single digits (7-9%).
  • The publishing/ printing industry is growing at a moderate rate ( 8-13 % on avg – see macmillan performance which has a similar business as Infomedia)
  • A fair valuation would be around 16-20 times free cash flow. Currently the free cash flow seems to be around 7-8 Rs / share. I would at best value the company at 160-180 Rs/share. So at 210 the company seems to fairly valued. Defintely not a long term buy at the current prices


So if I put the price after the buyback at around 180-190, the annualised return seems to be around 30%. Ofcourse the post-buyback price is just a guess on my part.

I still need to find how tendering of the shares is done? Does the company send some documents to the investor and is the investor supposed to fill up some papers to tender his shares? If anyone knows how the process works, please let me know or leave a comment.

An investment idea (In process)

A

I generally run a simple screen in icici direct to list all the companies selling below a PE of 12. Why a below 12? Well, there is a certain logic behind it and I will expand on it in another post.

So with the market at 10,000+ levels, the list has become fairly short with quite a few banks and commodity companies. I analysed a two companies (one looks interesting, the other one does not) and here are my thoughts on the first one (micro inks) which looks promising enough for further analysis.

Micro inks

As the name suggests, this is a 900+ cr company with the main business in inks. It is a kind of an Indian multinational with around 57% turnover coming from overseas (US accounting for almost 34%) and is fairly vertically integrated.

The company has done well in the last 5 years with CAGR growth of 20% in revenue and average net margins of 8-10%. See P&L here

The company has a fairly conservative
balance sheet with a low Debt to equity of 0.3. The ROE has been erratic but at a respectable 10% plus for a few years. Other Financial ratios look like Net margins, Operating margins have increased and are at healthy 10%+ and around 15-18 % for OPM. Account recievables are almost at 100 days, which is not healthy and a figure which needs to be watched closely. It is mainly at this level due to the type of marketing setup the company has (distributors, resellers etc)

The company has expanded its international operations through equity funding and moderate amounts of debt. This has a lower risk (for the company atleast) although the ROE is depressed now. Most of the investments seem to be in Subsidiaries and JV’s.

The company is valued at around 11 times last year PE. This year however has not been as good with profits declining due to raw material cost pressures. However the company still sells below 12-13 forward PE (Full year results are not yet in).

The numbers look fine (I need to read the annual report), but there some issues which I need to think through further

– How will the international strategy play out for microinks. Will the company be able to expand profitably in the international markets?
– What is the capital structure plan for the company. Will future expansion happen through equity (more dilution?)/ Debt or internal accruals?
– Competitior analysis

I have still not made up my mind on the above company, and will add to my analysis further as I read up on the company.I have done the basic checks on the company and nothing seems to be wrong on the face of it. In my case, it means that i will now be investing more time in understanding the industry dynamics, competitor analysis and try to understand the future economics of the company (mostly the soft stuff).

So typically i go through the annual report and the numbers as the first step and try to see if there is something off in terms of the numbers like high debt, excessive valuations or any other issues. If the investment idea passes the basic checks, i get into more detailed analysis which takes a few weeks for me.

My thoughts on sundaram clayton

M

I came across this post on sundaram clayton which got me interested in the checking on the company. On reading the annual report, this is what is found

  • sundaram clayton is in the business of auto-components – namely brakes and into aluminium castings
  • The company has a revenue of 5360 million rupees, NP of 534 million rupees
  • An average of ROCE of 20%+ with average Debt/equity ratio below 50 % (except current year where ratio is close to 50%)
  • Healthy NPM of 8-10% consistently across the years
  • Sundaram clayton is also know for its six sigma initiatives and has received several prefered supplier awards over the year

The company has several subsidiaries with a few associate companies too. The rough back of envelope calculation is as follows

The biggest holding is TVS motor company at 57%. A rough valuation is 16000 million (current year NP*12). The value of the holding is conservatively at 9120 million.
All the other subsidiaries are small with combined net profit of roughy 130 million. I would value is not more than 2000 million with Sundaram clayton value not exceeding 1500 million ( a very rough valuation).

So the total value of all the holding seems to be around 10620 million. With around 1090 million as debt and 25 million as cash , I would put the net value of these investment as 9600 million. The stock sells at 885 per share and with 18.9 million outstanding shares, the equity value is 16726 million. Back off the value of this investments and the company is valued at around 7100 million.

So with current EPS of 28, the PE comes to around 12-13.

Now all the above calculations are very rough. But it seems to be that the company is undervalued.
Although my initial analysis has not turned up anything negative, I would still not commit money to the stock as I still have figure out the following

  • The catalyst which could unlock the above value.
  • A more detailed analysis of the industry dynamics as there seems to be new competition coming up in the same segment as the company (there is mention of this in the management discussion)

Rational allocation of capital – A case study of Marico

R

First the disclaimer – The post is not an attempt to recommend marico as an investment (and definitely at these price levels). I do own the stock and have tracked the company for more than 5 years. The post is an attempt to give an example of a company which has a rational capital allocation policy. It does not mean that there are’nt other companies which do so. But I have found only a few companies which would return cash to the shareholder than just hoard it or worse just blow it in unrelated accquistions. Actually I have held stocks of a few such companies in the past.

Marico industries just announced the accquisiton of the brand nihar from HLL india for around 100 crores (not a 100 % sure on this) . This is however not the first brand accqusition of marico.

Marico has accquired a few small brands such as manjal and oil of malabar (not sure on this one) in the past. I have seen a resonably rational attitude towards capital allocation

This is a company with a consistent ROCE of 30% + and Debt equity of less than 0.2 for around 8-10 years. The company is in an industry with low to moderate growth rates (FMCG). As a result the company has had an excess of cash for quite some time.

Over the years I have seen the company do the following with the free cash flow

  • pay down the debt through the excess cash flows to close to 0 debt position by 2003-04 (the Debt equity ratio was as high as 0.8 in 1994)
  • Resonable dividend payout ratios of 40% or higher
  • Accquisition of brands / businesses in related businesses – hair care, skin care etc such as manjal, nihar and oil of malabar.
  • Development of business in related areas through new products/ services such as kaya or through geographical expansion in bangladesh and middle-east.
  • Return money to shareholder through preference issues (there was a bonus issue, but I would not call that return of capital)

Overall I have seen the capital allocation policy of the company to be fairly rational with the ROCE in excess of 30 % for the last 10+ years . In addition the company has a fairly detailed annual report and has quarterly updates which are more detailed than the annual report of several companies. Marico discusses in fair detail its business performance for every quarter.

Although there are companies which are better in terms of growth and return on capital than marico and I hold a few of them, my comfort with marico has been higher due to transparency of the company in terms of its communication. Have a look at their investor centre (go to the menu on the left) and you will agree with me. When I look for fresh investment opportunities, I try to compare the level of disclosure and communication of that company with what I get with marico.

Looking at exide industries

L

I came across a few research reports on exide industries and liked what I saw . In a nutshell

  • Exide industries is in the business of  Automotive batteries with brands such as Exide and Standard furukawa.
  • Exide supplies to OEM customers in cars ( Maruti, Hyundai, Ford etc), 2 wheelers ( Bajaj, Honda etc ) and has now made an considerable in roads in the tractor segment too. It has a very high market share of around 80%+ in the OEM segment
  • Exide has a dominant position in the replacement market ( 60%+) market share and a strong brand and extensive distribution network ( Read  competitive advantage )
  • Exide has a strong balance sheet with ROE in high teens and consistent topline and bottomline growth inspite of increases in lead prices ( lead account for around 65 % of Raw material costs )
  • Exide seems to have a reasonable pricing power due to its strong brand and is a preferred vendor for a number of OEM customers
  • The company is now expanding into the export market ( which accounts for only 5 % of the topline currently )
  • The next few years look good for the company as the Automotive sector ( cars, CV and 2 wheelers) has seen good growth and as the replacement cycle is around 18-24 months, strong demand from the both the OEM segment and replacement segment  should kick in.


A few negatives

  • Lead pricing would have an important bearing on the margins going forward. However over the next 2-3 years the impact of higher lead prices could be reduced if Exide is able to pass through the cost increases.
  • Valuation – The company is priced at around 15 times FY06 earnings. For me it is on the higher end of the price range. If I am able to get more comfortable and confident of the  business (need to read about other companies in this industry), then 15 times FY06 earnings may have a margin of safety. But for the time being, I am still evaluating and trying to get my arms around it.

Subscription

Enter your email address if you would like to be notified when a new post is posted:

I agree to be emailed to confirm my subscription to this list

Recent Posts

Select category to filter posts

Archives